Skip to main content

Advertisement

Log in

Genome editing for clinical HIV isolates

  • News & Views
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

An engineered recombinase removes the HIV-1 provirus from patient-derived cells and reduces infection in humanized mice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1: Summary of the current HIV-1 cure strategies and their primary obstacles.

References

  1. Finzi, D. et al. Nat. Med. 5, 512–517 (1999).

    Article  CAS  Google Scholar 

  2. Karpinksi, J.H.I., Chemnitz, J. & Buchholz, F. Nat. Biotechnol. 34, 401–409 (2016).

    Article  Google Scholar 

  3. Archin, N.M. et al. Nature 487, 482–485 (2012).

    Article  CAS  Google Scholar 

  4. Tebas, P. et al. N. Engl. J. Med. 370, 901–910 (2014).

    Article  CAS  Google Scholar 

  5. Hütter, G. et al. N. Engl. J. Med. 360, 692–698 (2009).

    Article  Google Scholar 

  6. Qu, X. et al. Nucleic Acids Res. 41, 7771–7782 (2013).

    Article  CAS  Google Scholar 

  7. Ebina, H. et al. PLoS One 10, e0120047 (2015).

    Article  Google Scholar 

  8. Hu, W. et al. Proc. Natl. Acad. Sci. USA 111, 11461–11466 (2014).

    Article  CAS  Google Scholar 

  9. Kaminski, R. et al. Sci. Rep. 6, 22555 (2016).

    Article  CAS  Google Scholar 

  10. Buchholz, F. & Stewart, A.F. Nat. Biotechnol. 19, 1047–1052 (2001).

    Article  CAS  Google Scholar 

  11. Sarkar, I., Hauber, I., Hauber, J. & Buchholz, F. Science 316, 1912–1915 (2007).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Robert F Siliciano.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kim, M., Siliciano, R. Genome editing for clinical HIV isolates. Nat Biotechnol 34, 388–389 (2016). https://doi.org/10.1038/nbt.3531

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.3531

  • Springer Nature America, Inc.

Navigation